mirikizumab

Ligand id: 9846

Name: mirikizumab

No information available.
Summary of Clinical Use
Phase 2 clinical trials which will evaluate mirikizumab (as research code LY3074828) in Crohn's disease (NCT02891226), ulcerative colitis (NCT02589665) and plaque psoriasis (NCT02899988) patients are underway.